• SENSEX
    NIFTY 50

Suboxone drug, USFDA approvals for plants will decide Dr Reddy's stock market rally

Updated : August 03, 2018 08:10 AM IST

DRL in a span of a few days sold $15-20 million worth of Suboxone generic boosting Q1 sales.
India, which reported 16 percent of sales and the second major market for the company, grew 30 percent YoY in Q1 supported by a low base.
Suboxone drug, USFDA approvals for plants will decide Dr Reddy's stock market rally
Published : August 02, 2018 04:48 PM IST

You May Also Like

Live TV

recommended for you

Advertisement